Semler Scientific (NASDAQ:SMLR) Trading Down 8.2% - What's Next?

Shares of Semler Scientific Inc. (NASDAQ:SMLR - Get Free Report) dropped 8.2% on Tuesday . The company traded as low as $41.31 and last traded at $41.53. Approximately 178,722 shares changed hands during trading, a decline of 69% from the average daily volume of 570,919 shares. The stock had previously closed at $45.23.

Wall Street Analyst Weigh In

SMLR has been the topic of a number of analyst reports. Maxim Group upgraded shares of Semler Scientific to a "strong-buy" rating and set a $95.00 price objective on the stock in a research report on Wednesday, July 9th. Benchmark initiated coverage on shares of Semler Scientific in a research report on Tuesday, July 8th. They set a "buy" rating and a $101.00 price objective on the stock. Finally, Wall Street Zen cut shares of Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.

Semler Scientific Trading Down 5.4%

The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.51 and a current ratio of 0.52. The company's fifty day simple moving average is $38.38 and its 200-day simple moving average is $41.37. The company has a market capitalization of $564.58 million, a P/E ratio of -15.80 and a beta of 1.39.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The business had revenue of $8.84 million for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.

Hedge Funds Weigh In On Semler Scientific

Several hedge funds have recently modified their holdings of SMLR. SummerHaven Investment Management LLC increased its holdings in Semler Scientific by 2.0% in the 2nd quarter. SummerHaven Investment Management LLC now owns 23,570 shares of the company's stock worth $913,000 after buying an additional 464 shares during the period. Kovitz Investment Group Partners LLC lifted its position in shares of Semler Scientific by 2.2% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 22,885 shares of the company's stock valued at $1,236,000 after buying an additional 501 shares in the last quarter. NewEdge Advisors LLC lifted its position in shares of Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after buying an additional 557 shares in the last quarter. BNP Paribas Financial Markets purchased a new position in shares of Semler Scientific during the 4th quarter valued at approximately $30,000. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in Semler Scientific by 10.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 6,226 shares of the company's stock valued at $225,000 after purchasing an additional 576 shares in the last quarter. Institutional investors and hedge funds own 49.37% of the company's stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.